Yoko Yamamoto

The use of PVP as a polymeric carrier to improve the plasma half-life of drugs

Yoshihisa Kaneda, Yasuo Tsutsumi, Yasuo Yoshioka et al. · Biomaterials · 2003 · 188 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +13

Functionalization of Tumor Necrosis Factor-α Using Phage Display Technique and PEGylation Improves Its Antitumor Therapeutic Window

Hiroko Shibata, Yasuo Yoshioka, Shinji Ikemizu et al. · Clinical Cancer Research · 2004 · 76 citations

Medicine, Oncology, Pharmacology +13

The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer

Miya Haruna, Azumi Ueyama, Yoko Yamamoto et al. · Scientific Reports · 2022 · 65 citations · Full text

Life Sciences, Immunology, Oncology +17

The targeting of anionized polyvinylpyrrolidone to the renal system

Hiroshi Kodaira, Yasuo Tsutsumi, Yasuo Yoshioka et al. · Biomaterials · 2003 · 64 citations

Pharmacy, Nephrology, Pharmaceutics +14

Antigenicity of mouse interferons: Distinct antigenicity of the two L cell interferon species

Yoko Yamamoto, Yoshimi Kawade · Virology · 1980 · 64 citations

Life Sciences, Cell Biology, Immunology +6